→
Labcorp Holdings Inc (LH) currently trades at $250.4, with a market cap of $20.53B and a P/E ratio of 21.81. The company's EPS growth year-over-year stands at an impressive 30.16%, indicating a strong operational performance, while its revenue growth rate of 7.34% supports a robust financial outlook. With a positive analyst consensus of 10 Strong Buy ratings and a 52-week high of $293.72, LH is well-positioned for future growth despite the recent price dip.
Investors should consider accumulating LH shares at current levels, given its strong growth metrics and favorable analyst sentiment.
Labcorp's strong EPS growth of 30.16% positions it favorably against peers in the health care sector. The company also consistently beats earnings estimates, as shown by its Q1 2026 performance of $4.25 versus an estimate of $4.2074, which further enhances investor confidence.
Despite its positive earnings trajectory, Labcorp's stock has faced a recent decline of 1.43% and is trading significantly below its 52-week high of $293.72. Additionally, its P/E ratio of 21.81 indicates that the stock may be overvalued relative to future earnings potential.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates LH as Bullish. Investors should consider accumulating LH shares at current levels, given its strong growth metrics and favorable analyst sentiment.
Despite its positive earnings trajectory, Labcorp's stock has faced a recent decline of 1.43% and is trading significantly below its 52-week high of $293.72. Additionally, its P/E ratio of 21.81 indicates that the stock may be overvalued relative to future earnings potential.
Labcorp's strong EPS growth of 30.16% positions it favorably against peers in the health care sector. The company also consistently beats earnings estimates, as shown by its Q1 2026 performance of $4.25 versus an estimate of $4.2074, which further enhances investor confidence.
Labcorp Holdings Inc (LH) currently trades at $250.4, with a market cap of $20.53B and a P/E ratio of 21.81. The company's EPS growth year-over-year stands at an impressive 30.16%, indicating a strong operational performance, while its revenue growth rate of 7.34% supports a robust financial outlook. With a positive analyst consensus of 10 Strong Buy ratings and a 52-week high of $293.72, LH is well-positioned for future growth despite the recent price dip.
Labcorp Holdings Inc (LH) currently trades at $250.4, with a market cap of $20.53B and a P/E ratio of 21.81. The company's EPS growth year-over-year stands at an impressive 30.16%, indicating a strong operational performance, while its revenue growth rate of 7.34% supports a robust financial outlook. With a positive analyst consensus of 10 Strong Buy ratings and a 52-week high of $293.72, LH is well-positioned for future growth despite the recent price dip. Our overall verdict is Bullish.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for LH at helmterminal.dev/analyze/LH, updated continuously during US market hours. No signup required.